Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$1.13B |
| 2 |
AT&T
T
|
+$275M |
| 3 |
Apple
AAPL
|
+$248M |
| 4 |
Walt Disney
DIS
|
+$235M |
| 5 |
Nike
NKE
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.4B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.17B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$863M |
| 4 |
Advanced Micro Devices
AMD
|
+$808M |
| 5 |
Amazon
AMZN
|
+$783M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.82% |
| 2 | Technology | 1.6% |
| 3 | Consumer Discretionary | 1.3% |
| 4 | Financials | 0.99% |
| 5 | Communication Services | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Mettler-Toledo International
MTD
$28.2B
| $13.1M | ﹤0.01% |
7,694
+4,025
| +110% | +$6.09M |
|
2327
PUT
NovoCure
NVCR
$2.09B
| $13M | ﹤0.01% |
173,700
-191,800
| -52% | -$19.3M |
|
2328
PUT
Polaris
PII
$3.63B
| $13M | ﹤0.01% |
118,500
-87,400
| -42% | -$10.3M |
|
2329
General Mills
GIS
$21.6B
| $13M | ﹤0.01% |
193,264
-238,681
| -55% | -$15.2M |
|
2330
Ecolab
ECL
$80.1B
| $13M | ﹤0.01% |
55,500
-108,996
| -66% | -$24.6M |
|
|
INFO
2331
PUT
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $13M | ﹤0.01% |
97,900
-124,900
| -56% | -$15.9M |
|
2332
PUT
W.W. Grainger
GWW
$62.2B
| $13M | ﹤0.01% |
25,100
-51,400
| -67% | -$24.2M |
|
2333
Fastenal
FAST
$58.7B
| $13M | ﹤0.01% |
406,064
+170,946
| +73% | +$5.04M |
|
2334
CALL
Fluor
FLR
$7.24B
| $13M | ﹤0.01% |
524,100
+4,400
| +0.8% | +$93.7K |
|
2335
PUT
iShares Russell 3000 ETF
IWV
$20.4B
| $13M | ﹤0.01% |
46,700
+36,900
| +377% | +$10M |
|
2336
PUT
Vulcan Materials
VMC
$35.5B
| $13M | ﹤0.01% |
62,400
-23,600
| -27% | -$4.57M |
|
2337
CALL
Clover Health Investments
CLOV
$2.25B
| $13M | ﹤0.01% |
3,481,400
-2,447,500
| -41% | -$15M |
|
2338
PUT
Canadian Imperial Bank of Commerce
CM
$105B
| $12.9M | ﹤0.01% |
221,800
+156,200
| +238% | +$9.09M |
|
|
VISN
2339
Vistance Networks Inc
VISN
$2.68B
| $12.9M | ﹤0.01% |
1,170,917
-51,258
| -4% | -$562K |
|
|
TE
2340
CALL
T1 Energy
TE
$1.46B
| $12.9M | ﹤0.01% |
1,154,100
+770,900
| +201% | +$8.35M |
|
2341
CALL
Ligand Pharmaceuticals
LGND
$5.67B
| $12.9M | ﹤0.01% |
133,851
+13,305
| +11% | +$1.23M |
|
2342
PUT
Digital Realty Trust
DLR
$71.3B
| $12.9M | ﹤0.01% |
72,900
-42,600
| -37% | -$6.82M |
|
2343
PUT
Teleflex
TFX
$5.84B
| $12.9M | ﹤0.01% |
39,200
-52,800
| -57% | -$18M |
|
2344
PUT
Trupanion
TRUP
$1.3B
| $12.9M | ﹤0.01% |
97,500
+24,300
| +33% | +$2.83M |
|
|
HZNP
2345
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $12.9M | ﹤0.01% |
119,400
-410,600
| -77% | -$44.8M |
|
2346
CALL
Harley-Davidson
HOG
$2.9B
| $12.9M | ﹤0.01% |
341,100
+103,100
| +43% | +$3.85M |
|
2347
Motorola Solutions
MSI
$80.5B
| $12.9M | ﹤0.01% |
47,304
+19,844
| +72% | +$5M |
|
|
PENG
2348
PUT
Penguin Solutions Inc
PENG
$2.69B
| $12.8M | ﹤0.01% |
362,000
+190,000
| +110% | +$5.39M |
|
2349
PUT
Darling Ingredients
DAR
$9.69B
| $12.8M | ﹤0.01% |
185,200
+93,100
| +101% | +$6.77M |
|
2350
KeyCorp
KEY
$23.5B
| $12.8M | ﹤0.01% |
554,720
+234,274
| +73% | +$5.44M |
|
Similar funds
Jeff Yass's Q4 2021 Portfolio in Review
As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
- Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
- Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
- Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
- Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
- Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
- Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.
Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.